Mitotherapeutix

1 follower


Mitotherapeutix develops siRNA-based drugs that focus on addressing difficult disease targets.

Employees

1-10

Links

Org chart

Jack Talley
Chief Executive Officer

Jack Talley

Collapse

Board & advisors

Robert Hennessey
Co-Founder & Chairman
Dan Wagner
Board Member
Fenel Eloi
Board Member
Richard Gregory
Scientific Advisory Chair
Mercedes Rincon
Scientific Advisor
James Digregori
Scientific Advisor
Gerald Shadel
Scientific Advisor
Maria Martinez-Chantar
Scientific Advisor
Wajahat Zafar Mehal
Scientific Advisor